[Skip to main content] [Skip to secondary navigation]

RNS Announcements

1  2  3  4  5  6  7  8  9  10  11  12   < Previous Next >

  • Issue of equity 28-03-08

    The Company announces that at Board meetings held on 25 March 2008 and 27 March 2008, 437,895 Ordinary Shares of 20p each in the Company (“Ordinary Shares”) were allotted at a price of £0.33 per Ordinary Share under the terms of the unlisted warrants issued on 24 January 2008, 113,513 Ordinary Shares of 20p each were allotted at a price of £0.32 per Ordinary Share under the terms of the unlisted warrants issued 25 January 2008, and 290,232 Ordinary Shares of 20p each were allotted at a price of £0.37 per Ordinary Share under the terms of the unlisted warrants issued 29 January 2008.

  • Issue of equity 28-02-08

    The Company announces that at a Board meeting held on 26 February 2008, under the terms of the facility agreement dated 17 January 2008, 808,889 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.45 per share and 323,556 Unlisted Warrants were granted with an exercise price of GBP 0.39 per share.

  • Issue of equity 31-01-08

    The Company announces that at a Board meeting held on 30 January 2008, under the terms of the facility agreement dated 17 January 2008, 725,581 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.43 per share and 290,232 Unlisted Warrants were granted with an exercise price of GBP 0.37 per share.

  • Issue of equity 28-01-08

    The Company announces that at a Board meeting held on 24 January 2008, under the terms of the facility agreement dated 17 January 2008, 1,094,737 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.38 per share and 437,895 Unlisted Warrants were granted with an exercise price of GBP 0.33 per share.

  • Issue of equity 21-01-08

    The Company announces that at a Board meeting held on 9 January 2008 under the terms of the facility agreement with Quivest BV, 3,000,000 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.50 per Ordinary Share.

  • Issue of equity and unlisted warrants 18-12-07

    The Company announces that at a Board meeting held on 13 December 2007, under the terms of the facility agreement dated 2 September 2006, 416,666 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.63 per share and 166,666 Unlisted Warrants were granted with an exercise price of GBP 0.52 per share. The enlarged issued share capital of the Company now consists of 52,931,152 Ordinary Shares.

  • Issue of equity 27-11-07

    The Company announces that at a Board meeting held on 27 November 2007, under the terms of settlement of creditor liabilities, 845,070 Ordinary Shares of 20p each were allotted at a price of €0.71 per share. The enlarged issued share capital of the Company now consists of 52,514,486 Ordinary Shares.

  • Issue of equity and unlisted warrants 02-11-07

    The Company announces that at a Board meeting held on 1 November 2007, under the terms of the facility agreement dated 2 September 2006, 301,724 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.87 per Ordinary Share and 120,690 Unlisted Warrants were granted with an exercise price of GBP 0.70 per share.

  • Grant of Options 19-10-07

    The Company announces that it has granted a total of 1,605,000 options to purchase new ordinary shares of 20p each ('Shares') on the 16 October 2007.

  • Issue of equity and unlisted warrants 12-10-07

    The Company announces that at a Board meeting held on 11 October 2007, under the terms of the facility agreement dated 2 September 2006, 350,000 Ordinary Shares of 20p (“Ordinary Shares”) each were allotted at a price of €0.90 per Ordinary Share and 140,000 Unlisted Warrants were granted with an exercise price of GBP 0.72 per share.

1  2  3  4  5  6  7  8  9  10  11  12   < Previous Next >